本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

13.06
-0.5300-3.90%
盘前13.250.1900+1.45%04:13 EDT
成交量:270.51万
成交额:3,572.92万
市值:11.59亿
市盈率:-3.88
高:13.66
开:13.63
低:12.99
收:13.59
52周最高:13.90
52周最低:7.36
股本:8,877.44万
流通股本:7,060.22万
量比:0.83
换手率:3.83%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
净资产收益率:-167.71%
总资产收益率:-31.30%
市净率:23.94
市盈率(LYR):-4.11

数据加载中...

2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report